Article Versions Notes

Moon ES, Van Rymenant Y, Battan S, De Loose J, Bracke A, Van der Veken P, De Meester I, Rösch F. In Vitro Evaluation of the Squaramide-Conjugated Fibroblast Activation Protein Inhibitor-Based Agents AAZTA⁵.SA.FAPi and DOTA.SA.FAPi. Molecules. 2021; 26(12):3482. https://doi.org/10.3390/molecules26123482

Moon, Euy Sung, Yentl Van Rymenant, Sandeep Battan, Joni De Loose, An Bracke, Pieter Van der Veken, Ingrid De Meester, and Frank Rösch. 2021. "In Vitro Evaluation of the Squaramide-Conjugated Fibroblast Activation Protein Inhibitor-Based Agents AAZTA⁵.SA.FAPi and DOTA.SA.FAPi" Molecules 26, no. 12: 3482. https://doi.org/10.3390/molecules26123482

Moon, E. S., Van Rymenant, Y., Battan, S., De Loose, J., Bracke, A., Van der Veken, P., De Meester, I., & Rösch, F. (2021). In Vitro Evaluation of the Squaramide-Conjugated Fibroblast Activation Protein Inhibitor-Based Agents AAZTA⁵.SA.FAPi and DOTA.SA.FAPi. Molecules, 26(12), 3482. https://doi.org/10.3390/molecules26123482